Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

Inclusion Criteria: * Adult participants who had inadequate response to \>= 2 non-steroidal anti-inflammatories (NSAIDs) * Participants who had arthritis or enthesitis or dactylitis plus: met spondyloarthritis clinical criteria * Negative purified protein derivative (PPD) test and Chest X-Ray performed at Baseline Visit were Negative * Ability to administer subcutaneous injections * General good health Exclusion Criteria: * Prior anti-tumor necrosis factor (TNF) therapy * Psoriasis or Psoriatic Arthritis * Fulfillment of modified New York criteria for Ankylosing Spondylitis * Recent infection requiring treatment * Significant medical events or conditions that had put patients at risk for participation * Female participants who were pregnant or breast-feeding or considering becoming pregnant during the study * History of cancer, except successfully treated skin cancer * Recent history of drug or alcohol abuse